选择性A2A激动剂在药物负荷试验中的新作用。 - Suppr

Suppr

超能文献

The emerging role of the selective A2A agonist in pharmacologic stress testing.

作者信息

Gemignani Anthony S, Abbott Brian G

机构信息

Division of Cardiology, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, USA.

出版信息

J Nucl Cardiol. 2010 Jun;17(3):494-7. doi: 10.1007/s12350-010-9211-9.

DOI:10.1007/s12350-010-9211-9

PMID:20221857

Abstract

摘要

相似文献

The emerging role of the selective A2A agonist in pharmacologic stress testing.

J Nucl Cardiol. 2010 Jun;17(3):494-7. doi: 10.1007/s12350-010-9211-9.

Regadenoson.

Am J Cardiovasc Drugs. 2010;10(1):65-71. doi: 10.2165/10489040-000000000-00000.

Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist.

J Cardiovasc Pharmacol. 2007 Jun;49(6):369-75. doi: 10.1097/FJC.0b013e318046f364.

An example of the clinical selectivity of regadenoson for the A2a adenosine receptor.

Am Heart Hosp J. 2009 Winter;7(2):E118-21. doi: 10.15420/ahhj.2009.7.2.118.

Daily Caffeine Consumption Is Associated with Decreased Incidence of Symptoms and Hemodynamic Changes During Pharmacologic Stress with Regadenoson.

J Nucl Med Technol. 2020 Mar;48(1):73-76. doi: 10.2967/jnmt.118.225219. Epub 2019 Oct 11.

Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications.

Cardiol Rev. 2013 Jan-Feb;21(1):42-8. doi: 10.1097/CRD.0b013e3182613db6.

Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.

JACC Cardiovasc Imaging. 2009 Oct;2(10):1198-208. doi: 10.1016/j.jcmg.2009.06.013.

Regadenoson (CV Therapeutics/Astellas).

Curr Opin Investig Drugs. 2006 Mar;7(3):264-71.

Indirect evidence of sympathetic stimulation by regadenoson.

J Nucl Cardiol. 2019 Apr;26(2):684-687. doi: 10.1007/s12350-018-1331-7. Epub 2018 Jun 13.

Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs.

J Pharmacol Exp Ther. 2003 Oct;307(1):182-9. doi: 10.1124/jpet.103.053306. Epub 2003 Sep 3.

引用本文的文献

Adenosine-caffeine: the agonist-antagonist couple for vasodilator stress tests.

J Nucl Cardiol. 2023 Apr;30(2):581-584. doi: 10.1007/s12350-022-03107-0. Epub 2022 Sep 19.

Adenosine A receptor agonist prevents cardiac remodeling and dysfunction in spontaneously hypertensive male rats after myocardial infarction.

Drug Des Devel Ther. 2017 Mar 6;11:553-562. doi: 10.2147/DDDT.S113289. eCollection 2017.

New Trends in Radionuclide Myocardial Perfusion Imaging.

Acta Cardiol Sin. 2016 Mar;32(2):156-66. doi: 10.6515/acs20150803a.

Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.

J Nucl Cardiol. 2017 Jun;24(3):1062-1070. doi: 10.1007/s12350-016-0452-0. Epub 2016 Mar 29.

Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge.

Int J Chron Obstruct Pulmon Dis. 2014 Jan 22;9:129-37. doi: 10.2147/COPD.S56879. eCollection 2014.

A delicate balance: CD73-generated adenosine limits the severity of graft vs. host disease but also constrains the allogeneic graft vs. tumor effect.

Oncoimmunology. 2013 Jan 1;2(1):e22107. doi: 10.4161/onci.22107.

Selective adenosine agonists and myocardial perfusion imaging.

J Nucl Cardiol. 2012 Feb;19(1):126-41. doi: 10.1007/s12350-011-9474-9.

Ischemic electrocardiogram during pharmacologic stress with regadenoson.

J Nucl Cardiol. 2011 Oct;18(5):978-80. doi: 10.1007/s12350-011-9426-4.

本文引用的文献

Safety of regadenoson in patients with end-stage renal disease.

Am J Cardiol. 2010 Jan 1;105(1):133-5. doi: 10.1016/j.amjcard.2009.08.663. Epub 2009 Nov 18.

Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.

JACC Cardiovasc Imaging. 2009 Oct;2(10):1198-208. doi: 10.1016/j.jcmg.2009.06.013.

Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.

JACC Cardiovasc Imaging. 2009 Aug;2(8):959-68. doi: 10.1016/j.jcmg.2009.04.011.

Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.

JACC Cardiovasc Imaging. 2008 May;1(3):307-16. doi: 10.1016/j.jcmg.2008.02.003.

Initial clinical experience with a selective A2A receptor agonist, regadenoson, in a patient with end-stage renal disease on hemodialysis.

J Nucl Cardiol. 2009 May-Jun;16(3):478-80. doi: 10.1007/s12350-008-9043-z. Epub 2009 Jan 22.

The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging.

J Nucl Cardiol. 2009 Jan-Feb;16(1):63-72. doi: 10.1007/s12350-008-9001-9. Epub 2009 Jan 20.

Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial.

J Nucl Cardiol. 2008 May-Jun;15(3):329-36. doi: 10.1016/j.nuclcard.2008.02.009. Epub 2008 Apr 14.

Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial).

J Nucl Cardiol. 2008 May-Jun;15(3):319-28. doi: 10.1016/j.nuclcard.2008.02.013. Epub 2008 Apr 14.

Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial.

J Am Coll Cardiol. 2008 Jan 22;51(3):328-9. doi: 10.1016/j.jacc.2007.10.014.

Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial.

J Nucl Cardiol. 2007 Sep-Oct;14(5):645-58. doi: 10.1016/j.nuclcard.2007.06.114.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验